Literature DB >> 32961334

Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study.

Benjamin Casteigt1, Michelle Samuel1, Laurence Laplante1, Azadeh Shohoudi1, Silke Apers2, Adrienne H Kovacs3, Koen Luyckx4, Corina Thomet5, Werner Budts6, Junko Enomoto7, Maayke A Sluman8, Chun-Wei Lu9, Jamie L Jackson10, Stephen C Cook11, Shanthi Chidambarathanu12, Luis Alday13, Katrine Eriksen14, Mikael Dellborg15, Malin Berghammer16, Bengt Johansson17, Andrew S Mackie18, Samuel Menahem19, Maryanne Caruana20, Gruschen Veldtman21, Alexandra Soufi22, Susan M Fernandes23, Kamila White24, Edward Callus25, Shelby Kutty26, Judith Brouillette1, Philip Moons27, Paul Khairy28.   

Abstract

BACKGROUND: Atrial arrhythmias (ie, intra-atrial reentrant tachycardia and atrial fibrillation) are a leading cause of morbidity and hospitalization in adults with congenital heart disease (CHD). Little is known about their effect on quality of life and other patient-reported outcomes (PROs) in adults with CHD.
OBJECTIVE: The purpose of this study was to assess the impact of atrial arrhythmias on PROs in adults with CHD and explore geographic variations.
METHODS: Associations between atrial arrhythmias and PROs were assessed in a cross-sectional study of adults with CHD from 15 countries spanning 5 continents. A propensity-based matching weight analysis was performed to compare quality of life, perceived health status, psychological distress, sense of coherence, and illness perception in patients with and those without atrial arrhythmias.
RESULTS: A total of 4028 adults with CHD were enrolled, 707 (17.6%) of whom had atrial arrhythmias. After applying matching weights, patients with and those without atrial arrhythmias were comparable with regard to age (mean 40.1 vs 40.2 years), demographic variables (52.5% vs 52.2% women), and complexity of CHD (15.9% simple, 44.8% moderate, and 39.2% complex in both groups). Patients with atrial arrhythmias had significantly worse PRO scores with respect to quality of life, perceived health status, psychological distress (ie, depression), and illness perception. A summary score that combines all PRO measures was significantly lower in patients with atrial arrhythmias (-3.3%; P = .0006). Differences in PROs were consistent across geographic regions.
CONCLUSION: Atrial arrhythmias in adults with CHD are associated with an adverse impact on a broad range of PROs consistently across various geographic regions.
Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Congenital heart disease; Intra-atrial reentrant tachycardia; Patient-reported outcomes; Quality of life

Mesh:

Year:  2020        PMID: 32961334     DOI: 10.1016/j.hrthm.2020.09.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  SOX7 loss-of-function variation as a cause of familial congenital heart disease.

Authors:  Ri-Tai Huang; Yu-Han Guo; Chen-Xi Yang; Jia-Ning Gu; Xing-Biao Qiu; Hong-Yu Shi; Ying-Jia Xu; Song Xue; Yi-Qing Yang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Application of Patient-Reported Outcome Measurements in Clinical Trials in China.

Authors:  Hui Zhou; Mi Yao; Xiaodan Gu; Mingrui Liu; Ruifeng Zeng; Qin Li; Tingjia Chen; Wen He; Xiao Chen; Gang Yuan
Journal:  JAMA Netw Open       Date:  2022-05-02

3.  Arrhythmias in adults with congenital heart disease and heart failure.

Authors:  Francis Bessière; Blandine Mondésert; Marie-A Chaix; Paul Khairy
Journal:  Heart Rhythm O2       Date:  2021-12-17

4.  The Adult Congenital Heart Disease Anatomic and Physiological Classification: Associations with Clinical Outcomes in Patients with Atrial Arrhythmias.

Authors:  Anastasios Kartas; Andreas S Papazoglou; Diamantis Kosmidis; Dimitrios V Moysidis; Amalia Baroutidou; Ioannis Doundoulakis; Stefanos Despotopoulos; Elena Vrana; Athanasios Koutsakis; Georgios P Rampidis; Despoina Ntiloudi; Sotiria Liori; Tereza Mousiama; Dimosthenis Avramidis; Sotiria Apostolopoulou; Alexandra Frogoudaki; Afrodite Tzifa; Haralambos Karvounis; George Giannakoulas
Journal:  Diagnostics (Basel)       Date:  2022-02-11

5.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

6.  Heart Failure and Patient-Reported Outcomes in Adults With Congenital Heart Disease from 15 Countries.

Authors:  Chun-Wei Lu; Jou-Kou Wang; Hsiao-Ling Yang; Adrienne H Kovacs; Koen Luyckx; Francisco Javier Ruperti-Repilado; Alexander Van De Bruaene; Junko Enomoto; Maayke A Sluman; Jamie L Jackson; Paul Khairy; Stephen C Cook; Shanthi Chidambarathanu; Luis Alday; Erwin Oechslin; Katrine Eriksen; Mikael Dellborg; Malin Berghammer; Bengt Johansson; Andrew S Mackie; Samuel Menahem; Maryanne Caruana; Gruschen Veldtman; Alexandra Soufi; Susan M Fernandes; Kamila White; Edward Callus; Shelby Kutty; Silke Apers; Philip Moons
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

7.  Identification of SOX18 as a New Gene Predisposing to Congenital Heart Disease.

Authors:  Hong-Yu Shi; Meng-Shi Xie; Chen-Xi Yang; Ri-Tai Huang; Song Xue; Xing-Yuan Liu; Ying-Jia Xu; Yi-Qing Yang
Journal:  Diagnostics (Basel)       Date:  2022-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.